US Patent Issued to Jazz Pharmaceuticals Ireland on Nov. 3 for "Modified L-asparaginase" (Irish, German Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,212, issued on Nov. 3, was assigned to Jazz Pharmaceuticals Ireland Ltd. (Dublin).

"Modified L-asparaginase" was invented by Lars Friedrich (Munich) and Anne O'Donnell (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof."

The patent was filed on Sept. 21, 2023, under Application No. 18/471,899.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov...